会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Cysteine protease inhibitors effective for in vivo use
    • 半胱氨酸蛋白酶抑制剂有效用于体内使用
    • US5374623A
    • 1994-12-20
    • US932791
    • 1992-08-20
    • Mary P. ZimmermanEugene R. BissellRobert E. Smith
    • Mary P. ZimmermanEugene R. BissellRobert E. Smith
    • A61K38/55A61P1/02A61P29/00A61P33/02A61P43/00C07C237/22C07C271/18C07C271/22C07C279/14C07D295/215C07K5/065A61K37/02C07K5/06C07K5/08C07K5/10
    • C07D295/215C07C271/18C07C271/22C07C279/14
    • A method of treating medical conditions with proteinase inhibitors of the formula: ##STR1## wherein B is H or an amino acid blocking group for the N-terminal amino acid nitrogen;R.sub.1 is an optionally protected .alpha.-amino acid side chain such that P.sub.2 is the residue of an .alpha.-amino acid selected from the group consisting of phenylalanine (Phe), leucine (Leu), tyrosine (Tyr) and valine (Val), and substituted analogs thereof, particularly including Tyr(OMe);R.sub.2 is an optionally protected .alpha.-amino acid side chain such that P.sub.1 is the residue of an .alpha.-amino acid selected from the group consisting of alanine (Ala), arginine (Arg), aspartic acid (Asp), glutamic acid (Glu), histidine (His), homophenylalanine (HPhe), phenylalanine (Phe), ornithine (Orn), serine (Ser) and threonine (Thr), and substituted analogs thereof;X is a fluorine-free leaving group selected from the group consisting of phenoxy, substituted phenoxy and heterophenoxy;E and G are one or more atoms more electronegative than carbon; andD is hydrogen, methyl or a substituted methyl.
    • 用下式的蛋白酶抑制剂治疗医学病症的方法:其中B是H或N-末端氨基酸氮的氨基酸封闭基团; R1是任选保护的α-氨基酸侧链,使得P2是选自苯丙氨酸(Phe),亮氨酸(Leu),酪氨酸(Tyr)和缬氨酸(Val)的α-氨基酸的残基,以及 其取代的类似物,特别包括Tyr(OMe); R2是任选保护的α-氨基酸侧链,使得P1是选自丙氨酸(Ala),精氨酸(Arg),天冬氨酸(Asp),谷氨酸(Glu)的α-氨基酸的残基。 ,组氨酸(His),高苯丙氨酸(HPhe),苯丙氨酸(Phe),鸟氨酸(Orn),丝氨酸(Ser)和苏氨酸(Thr)及其取代的类似物; X是选自苯氧基,取代的苯氧基和异苯氧基的无氟离去基团; E和G是一个或多个比碳更负电的原子; D为氢,甲基或取代甲基。
    • 5. 发明授权
    • Amino acid substituted-cresyl violet, synthetic fluorogenic substrates for the analysis of agents in individual in vivo cells or tissue
    • 氨基酸取代的甲酚紫,用于分析个体体内细胞或组织中的试剂的合成荧光底物
    • US06235493B1
    • 2001-05-22
    • US09130193
    • 1998-08-05
    • Eugene R. BissellRobert F. Smith
    • Eugene R. BissellRobert F. Smith
    • C12Q137
    • C12Q1/37C12Q2337/00
    • The present invention concerns a method to detect the presence of an enzyme in in vivo or in vitro tissue or cell, which method comprises: (a) obtaining a tissue or cell sample to be analyzed; (b) contacting the tissue or cell sample with a substrate of the structure selected from the group consisting of: X=H or one or more natural or synthetic amino acids with or without amino blocking groups, Y=H or one or more natural or synthetic amino acids with or without amino blocking groups, wherein X and Y are the same or different and are amino acid sequences of between about 1 to 1,000,000 amino acids wherein each amino acid is the same or a different amino acid, with the proviso that at least one of X or Y is at least one amino acid; (c) when an enzyme is present in the tissue or cell sample which degrades X, Y and combinations thereof, fluorescent cresyl violet is released in the tissue sample producing a color change; (d) detecting the presence and amount of the enzyme present by the detection and quantification of the fluorescence produced; and (e) optionally comparing the fluorescence to a pre-calibrated fluorescence scale to quantify the fluorescence present. A diagnostic kit for use and a method to prepare amino acid cresyl violet derivatives are described.
    • 本发明涉及检测体内或体外组织或细胞中酶的存在的方法,该方法包括:(a)获得要分析的组织或细胞样品;(b)使组织或细胞样品与 具有或不具有氨基封闭基团的Y = H或一个或多个具有或不具有氨基封闭基团的天然或合成氨基酸的Y = H或一个或多个天然或合成氨基酸的结构的底物,Y = 其中X和Y相同或不同,为约1至1,000,000个氨基酸的氨基酸序列,其中每个氨基酸相同或不同氨基酸,条件是X或Y中的至少一个为至少一个 氨基酸;(c)当酶在组织或细胞样品中存在降解X,Y及其组合时,荧光甲酚紫在组织样品中释放产生颜色变化;(d)检测 通过检测存在酶 并定量产生的荧光; 和(e)可选地将荧光与预校准的荧光标度进行比较以量化存在的荧光。 描述了使用的诊断试剂盒和制备氨基酸甲酚紫衍生物的方法。